munication). They present typically as macropapular erythematous rashes, though dermatographism, nausea, vertigo, and malaise have also been reported. The reactions commonly develop several hours after administration of the radiopharmaceutical and may last up to 48 hours. These localised reactions are considered to be minor, and only one other severe systemic reaction has been described; in that case rechallenge by skin testing proved a causal relation.' We thought that rechallenge was unwise in our case given the severity of the reaction.
munication). They present typically as macropapular erythematous rashes, though dermatographism, nausea, vertigo, and malaise have also been reported. The reactions commonly develop several hours after administration of the radiopharmaceutical and may last up to 48 hours. These localised reactions are considered to be minor, and only one other severe systemic reaction has been described; in that case rechallenge by skin testing proved a causal relation. ' We thought that rechallenge was unwise in our case given the severity of the reaction.
Diphosphonates are present in several radiopharmaceuticals other than those used for bone scanning; examples are agents for labelling red cells (Amerscan Stannous Agent, Amersham International) and imaging the liver (Microlite, Du Pont (United Kingdom)). Alternative agents should thus be used for patients known or suspected to be sensitive to diphosphonates; bone scanning may be done with pyrophosphates. In addition, hypersensitivity reactions may occur in patients with Paget's disease being treated with therapeutic concentrations of diphosphonates. The radiopharmaceutical that we injected contained only 0 5 mg diphosphonate, whereas single therapeutic doses are in the range 15-30 mg34 and are administered by intravenous infusion over less than two hours. We therefore suggest that skin testing for sensitivity be considered when pharmaceuticals containing diphosphonates are used therapeutically and it would not compromise management of the patient. showed necrosis of the pancreatic body and tail. On the eighth day of the attack he became hypertensive, unconscious, and unresponsive, with increasing fever despite antibiotics. A 1-8 litre plasma exchange was performed as in case 1. Confusion cleared rapidly, vital signs and oxygenation improved, fever decreased (figure), and the APACHE II score fell from 17 to 9. Next day the necrotic pancreatic tail and body were debrided at laparotomy and irrigating drains inserted. He made a complete recovery and was discharged 38 days later.
Comment
Many patients with fulminant acute pancreatitis have pancreatic necrosis, and survival depends on debridement of necrotic or infected tissue. Ifoperation is undertaken during the initial week survival is unlikely,4 and the outlook is similarly bleak if multiorgan failure becomes established.' There is a logical role for treatments that allow debridement to be undertaken at a stage when recovery can be expected. Plasmapheresis scavenges various circulating toxins, including protease-U2 macroglobulin complexes. Our findings are preliminary, but the similarity of response was impressive, and in both cases there was a large reduction in the APACHE II score with the expectation of an increased probability of survival. Human leucocyte antigen in a Chinese family with thyrotoxic periodic paralysis in Singapore
Periodic paralysis is a dramatic complication in some patients who have thyrotoxicosis (Graves' disease). It occurs more commonly in thyrotoxic men of Mongoloid descent. The familial occurrence of thyrotoxic periodic paralysis is, however, infrequent. To date there have been only a few reports of familial thyrotoxic periodic paralysis. Most reports have been based on a positive family history elicited during questioning of the patient. We report the first, to our knowledge, documented occurrence of familial thyrotoxic periodic paralysis in a Chinese family in Singapore together with the human leucocyte antigen genotypes of the family members. 195 IU/l (normal < 10 IU/1). He was treated with oral potassium supplements together with propranolol and carbimazole. The next day he had completely regained his muscular power. The case records of all his immediate family members who had thyrotoxicosis or thyrotoxic periodic paralysis, including a thyrotoxic maternal uncle, were recalled and studied. Subsequently the human leucocyte antigen type of all the immediate family members and maternal uncle was tested with the National Institutes of Health lymphocyte microcytotoxicity method.' The figure shows the pedigree and human leucocyte antigen genotypes of the family.
Lately there has been much interest in the genetics of thyrotoxicosis and thyrotoxic periodic paralysis. Chan et al reported an association between human leucocyte antigen Bw46 and DR9 and thyrotoxicosis in Chinese patients.2 Those members of the family whom we studied who had documented thyrotoxicosis (with or without periodic paralysis) were haplotype A or B, each of which contains the alleles DR9, DRw53, and DQw3.
In addition, Yeo et al showed that the haplotypes A2 Bw22 and Aw19 B17 were associated with thyrotoxic periodic paralysis among Chinese patients in Singapore.3 It was reported that Bw22 and B17 were in linkage disequilibrium with A2 and Awl9, respectively. In another study Cheah concluded that it was the alleles Bw22 and B 17 that carried an increased relative risk for thyrotoxic periodic paralysis.4 He also observed that the haplotype A2 Bw22 occurred only in Chinese thyrotoxic patients who had periodic paralysis and was absent in Chinese thyrotoxic patients who did not have periodic paralysis.
In the family that we studied, besides the two siblings who had thyrotoxic periodic paralysis, three other siblings were haplotype A thus carrying the allele Bw22. It is tempting to speculate that thyrotoxic periodic paralysis may occur in these three siblings should the thyrotoxic state recur.
Familial thyrotoxicosis occurs more commonly than familial thyrotoxic periodic paralysis. Several studies of human leucocyte antigen have been performed in such families. On reviewing the cumulative results of studies of white and Chinese subjects Tian et al noted that of 36 different families that had multiple cases of
